Moberg Pharma AB (publ) (STO:MOB)
11.36
+0.24 (2.16%)
Sep 4, 2026, 5:29 PM CET
Moberg Pharma AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 536 | 483 | 475 | 425 | 228 | 237 | |
Market Cap Growth | 15.89% | 1.65% | 11.73% | 86.42% | -3.61% | 65.26% |
Enterprise Value | 325 | 249 | 170 | 327 | 87 | 130 |
Last Close Price | 11.36 | 10.27 | 10.17 | 15.20 | 23.20 | 51.85 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 31.57 |
Forward PE | - | 91.90 | 91.90 | 91.90 | 91.90 | 91.90 |
PS Ratio | 31.98 | 35.66 | 48.40 | - | 1101.38 | - |
PB Ratio | 0.81 | 0.73 | 0.69 | 0.70 | 0.43 | 0.55 |
P/TBV Ratio | 0.81 | 0.73 | 0.69 | 0.70 | 0.43 | 0.55 |
PEG Ratio | - | 115.56 | 115.56 | 115.56 | 115.56 | 115.56 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 19.41 | 18.43 | 17.28 | - | 421.77 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
Net Debt / Equity Ratio | -0.32 | -0.34 | -0.42 | -0.09 | -0.22 | -0.23 |
Net Debt / EBITDA Ratio | 10.59 | 8.37 | 0.89 | 2.07 | 6.09 | 5.00 |
Net Debt / FCF Ratio | 15.67 | 13.06 | 17.56 | 1.68 | 7.09 | 6.45 |
Asset Turnover | 0.02 | 0.02 | 0.02 | - | 0 | - |
Inventory Turnover | 1.12 | 1.49 | 0.61 | - | - | - |
Quick Ratio | 12.05 | 14.45 | 17.59 | 2.99 | 4.74 | 6.68 |
Current Ratio | 12.26 | 14.71 | 17.95 | 3.38 | 4.77 | 6.74 |
Return on Equity (ROE) | -3.22% | -4.03% | -39.32% | -3.69% | -3.25% | -3.91% |
Return on Assets (ROA) | -1.86% | -2.52% | -30.29% | -2.91% | -2.53% | -2.65% |
Return on Invested Capital (ROIC) | -4.62% | -6.71% | -68.21% | -5.76% | -5.47% | -5.49% |
Return on Capital Employed (ROCE) | -3.10% | -4.20% | -47.10% | -4.50% | -3.80% | -4.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -4.03% | -5.64% | -53.72% | -4.96% | -6.89% | 3.17% |
FCF Yield | -2.51% | -3.62% | -3.47% | -7.81% | -7.39% | -6.47% |
Buyback Yield / Dilution | -0.66% | -23.78% | -138.46% | -109.19% | -76.28% | -127.45% |